GlassScriptPhysician profile
Donna A Holscher
NPI 1306971148
$1,288.28
in general payments reported to CMS, 2019-2025
20 companies · $37.15 in 2025
The $37.15 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $822 · 2020: $168 · 2021: $217 · 2023: $44.48 · 2025: $37.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $81.63.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $81.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $258.14 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $238.45 | 2019-2021 | |
| Pfizer INC. | $146.24 | 2019-2021 | |
| Glaxosmithkline, LLC. | $112.77 | 2019-2021 | |
| Indivior INC. | $106.67 | 2019-2023 | Sublocade |
| Astrazeneca Pharmaceuticals LP | $72.10 | 2019-2021 | |
| Lilly USA, LLC | $52.32 | 2019-2021 | |
| Adamas Pharmaceuticals, INC. | $51.87 | 2019 | |
| Abbvie INC. | $50.94 | 2021-2023 | |
| Novartis Pharmaceuticals Corporation | $36.30 | 2019 | |
| Alkermes, INC. | $22.66 | 2019 | |
| Edwards Lifesciences Corporation | $19.65 | 2025 | Sapien 3 Ultra Resilia |
| Mdd US Operations, LLC | $18.39 | 2019 | |
| Abbott Laboratories | $17.50 | 2025 | Id Now Instrument |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $17.29 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $16.25 | 2019 | |
| Merck Sharp & Dohme LLC | $15.59 | 2019 | |
| Dexcom, INC. | $12.66 | 2021 | |
| Sunovion Pharmaceuticals INC. | $11.68 | 2020 | |
| Sanofi Pasteur INC. | $10.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donna Holscher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.